We are live on
!
Find out more
PAND
Pandion Therapeutics Inc. Common Stock
PAND
PAND
Delisted
PAND was delisted on the 31st of March, 2021.
0 hedge funds and large institutions have $0 invested in Pandion Therapeutics Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 75 → 0 (-75)
100% less capital invested
Capital invested by funds: $515M → $0 (-$515M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 75
Holders
–
Holders Change
-75
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
75
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
BlackRock
New York
|
-$64.5M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$63M |
| 3 |
Goldman Sachs
New York
|
-$47.8M |
| 4 |
VI
Versor Investments
New York
|
-$44.6M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$43.5M |
